Tag: the war on (some) drugs

Marijuana Seizures At U.S.–Mexico Border Continue To Fall As More States Legalize, Federal Data Shows

As the state marijuana legalization movement continues to expand, seizures of cannabis at southern border declined again in 2023, according to data from U.S. Customs and Border Protection (CBP).

The latest figures show agents intercepted roughly 61,000 pounds of cannabis in the region—a 29 percent drop from the year before.

The new numbers represent an ongoing decline in illicit marijuana seizures by border agents as more U.S. state legalization laws come online. In 2022, CBP authorities seized 154,797 pounds of cannabis nationwide—about half of the 319,447 pounds that were seized the year before.

Advocates for legalization say the data from the southern border is further evidence that state-regulated markets are shrinking demand for imported Mexican marijuana.

“When it comes to cannabis, the prevailing attitude is ‘Buy American,’” NORML Deputy Director Paul Armentano said in a statement about the trend. “The rise of the regulated state-legal cannabis market has not only supplanted Americans’ demand for Mexican cannabis, but in many places it has also disrupted the unregulated domestic marketplace.”

NORML noted that the 2023 figures mark a 98 percent decline in seized cannabis at the U.S.–Mexico border since 2013, when more than 2.4 million pounds were intercepted.

The advocacy group also cited a survey from last year in which 52 percent of U.S. cannabis consumers said they primarily obtain marijuana from brick-and-mortar establishments. The poll found that just 6 percent said they primarily get cannabis from a “dealer.”

As reports in recent years have pointed out, the dynamic has shifted so significantly that, at least in some cases, U.S. marijuana is now being smuggled into Mexico, where it commands premium prices. One vehicle recently stopped by authorities as it traveled from California to Tijuana held 5,600 jars of THC-infused gummies.

NORML said similar dynamics are being observed in Canada. In 2019, the first full year of legalization in that country, just over a third (37 percent) of consumers reported buying marijuana from legal sources. By 2022, that share had nearly doubled, to 69 percent. At that point, only 4 percent of respondents said they still purchased cannabis on the unregulated market.

The CBP data tracks with other indications of declines in illegal marijuana trafficking as a growing number of state laws give American consumers legal places to buy cannabis, including a March report from the U.S. Sentencing Commission that showed federal cases continue to fall.

While that report didn’t cite the specific number of marijuana trafficking cases in 2023, it dipped again compared to the previous 2022 low of 806, according to an included chart. By comparison, there were roughly 5,000 cannabis cases in 2013.

Meanwhile, cases involving fentanyl and powder cocaine increased again last year. Drug cases overall made up 29.9 percent of the federal criminal caseload, the second-largest category after immigration-related offenses.

Keep reading

Do dying people have a ‘right to try’ magic mushrooms? 9th Circuit weighs case

Do dying patients have a “right to try” illegal drugs such as psilocybin and MDMA if they might alleviate end-of-life suffering from anxiety and depression?

That question is now before one of the nation’s highest courts, with a Seattle-based palliative care physician appealing a U.S. Drug Enforcement Administration decision barring him from prescribing psilocybin to his late-stage cancer patients.

Dr. Sunil Aggarwal says he has a right to prescribe psilocybin—the hallucinogenic compound in “magic mushrooms”—under state and federal “right to try” laws, which give terminal patients access to experimental drug therapies before they are approved by the U.S. Food and Drug Administration. More than 40 states, including Washington and California, have such laws in place, and Congress passed a federal version in 2018.

“I have patients who want to try psilocybin-assisted therapy for existential distress,” Aggarwal said in an interview with The Times. “And there are lots of studies that support that.”

The DEA has denied Aggarwal’s request, arguing that therapeutic use of psilocybin remains banned—even for terminal patients—under the Controlled Substances Act of 1970, which lists the drug as a “Schedule I” narcotic with no recognized medical use. The agency said Aggarwal could only work with the drug if he received a license to do so as a researcher, not as a regular part of his palliative care practice.

The case is one of two Aggarwal now has pending before the 9th Circuit, each pitting the DEA’s law enforcement authority against state powers to regulate medicine. In the second case, Aggarwal is asking the DEA to simply reschedule psilocybin, making it available for therapy—not just research.

Physicians and medical experts across the country are closely watching the “right to try” case, and eight states and the District of Columbia have weighed in directly in support of Aggarwal.

In February, the state coalition filed a brief that accused the DEA of reaching far beyond its law enforcement role of preventing the illegal diversion of powerful narcotics. They said the DEA’s assertion that the Controlled Substances Act trumps state right-to-try laws represented a “threat to state sovereignty.”

Keep reading

Trump Planning to Send Covert ‘Assassination Squads’ to Mexico to Take Out Cartel Leaders

Donald Trump is reportedly planning to send covert “assassination squads” into Mexico as soon as he takes office in order to take out Mexican drug cartel leaders wreaking havoc on America.

According to a report from Rolling Stone, Trump is mulling the idea if he returns to the White House next year as part of an effort to strike “fear into the hearts” of Mexico’s most notorious drug lords:

The former president has not presented specific details in public about these plans — for example, how many U.S. troops he’d be willing to send into sovereign Mexican territory. But, the three sources tell Rolling Stone, in conversations with close MAGA allies, including at least one Republican lawmaker, Trump has privately endorsed the idea of covertly deploying — with or without the Mexican government’s consent — special-ops units that would be tasked with, among other missions, assassinating the leaders and top enforcers of Mexico’s powerful and most notorious drug cartels. In some of these discussions, Trump has insisted that the U.S. military has “tougher killers than they do” and pondered why these assassination missions haven’t been done before, arguing that eliminating the heads of cartels would go a long way toward hobbling their operations and striking fear into the hearts of “the kingpins.”

…

During some of these conversations, Trump has likened these proposals to the 2019 military raid that he ordered that resulted in the death of ISIS leader Abu Bakr al-Baghdadi, insisting that the U.S. should approach drug cartel leadership in the same manner. One of the sources, who discussed the issue with Trump earlier this year, recalls the ex-president saying that the U.S. government should have a “kill list of drug lords,” as this source describes Trump’s ideas, of the most powerful and infamous cartel figures that American special forces would be assigned to kill or capture in a potential second Trump administration.

Trump has made no secret of his plans to deal with Mexico’s drug cartels should he get a second term in office. Since Joe Biden seized power in January 2021, drug cartels have expanded their operations across the United States by taking advantage of the open border, flooding the country with fentanyl and a host of other deadly substances.

Keep reading

Cannabis Can Help Treat Female Orgasmic Disorder, Study Finds As Ohio Officials Consider Adding It As Qualifying Condition

Ahead of a decision by Ohio officials on whether to add female orgasmic disorder (FOD) as a qualifying condition for the state’s medical marijuana program, a new study highlights the benefits that researchers say cannabis could offer people with the condition—including increased orgasm ease and satisfaction.

The 10-page study, published in the journal Sexual Medicine, draws on a 2022 survey of “sexually active women who used cannabis.” Among those who experienced challenges in achieving orgasm, more than 7 in 10 said cannabis use increased orgasm ease (71 percent) and frequency (72.9 percent), and two-thirds (67 percent) said it improved orgasm satisfaction.

“The results corroborate 50 years of anecdotal and learned speculation about cannabis helping women with FOD,” the paper says. “The research found that cannabis use increased orgasm frequency, eased orgasm difficulty, and improved orgasm satisfaction. At the same time, the results opened new areas of discussion.”

For example, results of the survey found that women with one or more mental health diagnoses who used cannabis before partnered sex had “a more positive orgasm response regardless of whether they have FOD,” which authors noted was “consistent with research finding that women with FOD experience high rates of mental health diagnoses, prescription drug use, or PTSD.”

Keep reading

Former Biden Cabinet Member Is ‘Concerned’ About Marijuana Legalization

A former U.S. labor secretary who previously served as mayor of Boston as Massachusetts’s marijuana legalization law came into effect, spoke out against what he described as a “slippery slope” of cannabis reform during a C-SPAN interview this week.

Marty Walsh, who also discussed his own substance use disorder and recovery in the interview, said he’s “worried” about legalization efforts and gets “concerned about where we’re headed there.”

Asked how he felt about his state’s move to legalize, the former Biden cabinet member replied: “I didn’t love it. When I was mayor of Boston, I fought it. I get concerned. I think it’s a slippery slope.”

Walsh, who opposed the 2016 ballot initiative to legalize marijuana in his state and later voted against a proposed Democratic National Committee party plank to endorse cannabis legalization in 2020, noted that advocates at first seemed to want to decriminalize marijuana, then later pushed legalize it for medical uses.

“And now you have marijuana” legal for adults, he added. “And I’m just worried, you know. You have have some places in the country trying to legalize it and opioids. I get concerned about that. I just get concerned about where we’re headed there.”

Later in the interview, he claimed that “alcohol deaths are higher than, actually, opioid deaths at this point in our country,” and argued that manufacturers of dangerous or impairing substances should be liable for costs of therapy and recovery.

Keep reading

GOP Senator Says Marijuana Is A ‘Gateway Drug,’ And Legalization Is A ‘Pro-Criminal, Anti-American’ Policy

A Republican senator says marijuana is a “gateway drug,” and Democrats’ moves to legalize it reflect “pro-criminal, anti-American policies” that will “stimulate more crime on American streets.” He also argued that cannabis banking legislation “facilitates an entire infrastructure and an ecosystem for more drug usage in America.”

Sen. Bill Hagerty (R-TN) said during an interview on Thursday that he’s opposed to both comprehensive legalization legislation such as the bill Senate Majority Leader Chuck Schumer (D-NY) and 17 other Democrats reintroduced this week, as well as modest reform like the Secure and Fair Enforcement Regulation (SAFER) Banking Act.

“What the Joe Biden administration—what Leader Schumer—is trying to do is basically stimulate more crime on American streets,” Hagerty said. “Here we have Chuck Schumer basically lowering the barriers for gateway drugs like marijuana, and it’s going to damage society, and this is exactly what Democrats have been pushing. This is not good for America.”

He added that the push for cannabis legalization is an attempt to “incentivize more drug usage in America.”

Asked for his thoughts on the SAFER Banking Act to simply protect financial institutions that work with state-licensed marijuana businesses, the senator said it “facilitates an entire infrastructure, an ecosystem, for more drug usage in America.”

“We need to be constraining drug usage, not encouraging it,” he said.

Hagerty said that Democrats’ marijuana reform efforts are “completely political,” designed to shore up support from a “small fragment” of voters who care about cannabis policy ahead of the November election.

“What they’re trying to do is cobble together a very disparate group of people to vote for Joe Biden,” he said. “Nobody likes his overall policies. If you look at American sentiment, everyone says that America is moving in the wrong direction. But what they’re trying to do is pick off minor issues like this—encouraging drug abuse, frankly. It’s obscene that this would be happening.”

Keep reading

NYPD union sues over officers’ rights to use steroids

Lawyers from the Police Benevolent Association have filed a lawsuit against NYPD Police Commissioner Edward Caban and Mayor Adams over recent policy changes relating to the use of performance enhancing drugs such as steroids by active duty officers. From NY Daily News:

The 2011 contract prohibited officers from ingesting or possessing any anabolic steroid or other forms of human growth hormones without a medical prescription. However, the old standard didn’t require officers to run any such prescription by their NYPD district surgeon before starting to use it.

The new protocol — which was enacted on Dec. 26, 2023, and described in an internal memo reviewed by The News as a “zero tolerance drug policy” — beefs up the old rule by affirming that officers must “immediately notify their district surgeon” of any steroid prescription they receive and provide “all supporting medical documentation” to the surgeon backing up the need for the drug.

If officers are caught violating the new rule by, for example, deviating from a prescribed dosage, they can face firing, the memo says.

Keep reading

Rescheduling Marijuana Does Not Address Today’s Central Cannabis Issue

The Justice Department yesterday confirmed that the Drug Enforcement Administration  (DEA) plans to move marijuana from Schedule I of the Controlled Substances Act (CSA), a list of completely prohibited drugs, to Schedule III, which includes prescription medications such as ketamine, Tylenol with codeine, and anabolic steroids. The Associated Press notes that the change, which is based on an August 2023 recommendation by the Department of Health and Human Services (HHS) that resulted from a review President Joe Biden ordered in October 2022, “would not legalize marijuana outright for recreational use.”

That is by no means the only thing rescheduling marijuana will not do. Biden wants credit for “marijuana reform,” which he hopes will help motivate young voters whose turnout could be crucial to his reelection. The announcement of the DEA’s decision seems designed to maximize its electoral impact. But voters should not be fooled: Although moving marijuana to Schedule III will facilitate medical research and provide a financial boost to the cannabis industry, it will leave federal pot prohibition essentially untouched.

Rescheduling marijuana will not resolve the conflict between the CSA and the laws of the 38 states that recognize cannabis as a medicine, 24 of which also allow recreational use. State-licensed marijuana businesses will remain criminal enterprises under federal law, exposing them to the risk of prosecution and forfeiture. While an annually renewed spending rider protects medical marijuana suppliers from those risks, prosecutorial discretion is the only thing that protects businesses serving the recreational market.

Even if they have state licenses, marijuana suppliers will be in the same legal position as anyone who sells a Schedule III drug without federal permission. Unauthorized distribution is punishable by up to 10 years in prison for a first offense and up to 20 years for subsequent offenses. That is less severe than the current federal penalties for growing or distributing marijuana, which include five-year, 10-year, and 20-year mandatory minimum sentences, depending on the number of plants or amount of marijuana. But distributing cannabis, with or without state permission, will remain a felony.

That reality suggests that banks will remain leery of providing financial services to state-licensed marijuana suppliers, which entails a risk of potentially devastating criminal, civil, and regulatory penalties. The dearth of financial services has forced many cannabis suppliers to rely heavily on cash, which is cumbersome and exposes them to a heightened risk of robbery. It also makes investment in business expansion difficult.

Although federal arrests for simple marijuana possession are rare, cannabis consumers likewise will still be committing crimes, even if they live in states that have legalized marijuana. Under 21 USC 844, possessing a controlled substance without a prescription is a misdemeanor punishable by a minimum $1,000 fine and up to a year in jail. Moving marijuana to Schedule III will not change that law, which only Congress can do. Nor did President Joe Biden’s mass pardons for people convicted of simple marijuana possession under that statute, which apply only retrospectively, “decriminalize the use of cannabis,” as he promised to do during his 2020 campaign.

Keep reading

Marijuana Legalization Opponents Raise Money For Potential Lawsuit Against Federal Rescheduling Move

A day after the Drug Enforcement Administration’s (DEA) decision that marijuana will move to the less-restrictive Schedule III of the Controlled Substances Act, a leading cannabis prohibition group sent an email to supporters asking for money to fuel its fight against the reform.

“SAM will oppose this change at every level, including, if necessary, pursuing legal action,” the group, Smart Approaches to Marijuana, wrote in the email on Wednesday.

An included link to what SAM describes as a “Rescheduling Legal Defense Fund” asks for one-time or monthly recurring donations of between $250 and $5,000, though supporters can also choose an “other” amount.

“Our new Rescheduling Legal Defense Fund will be used to support our challenges of marijuana laws and regulations, specifically marijuana’s Schedule III recommendation,” the donation page says.

SAM, one of the most outspoken organizations against legalizing marijuana, then cited its representatives’ multiple recent appearances in national news and print media.

“Let’s be clear: this does not mean marijuana is legalized—it will remain federally illegal,” SAM said in its fundraising email. “But, if implemented, moving marijuana to Schedule III would give Big Marijuana billions in tax write-offs as well as continue the normalization of high-potency THC drugs.”

SAM did not immediately provide more details about the possible legal action in response to a query from Marijuana Moment.

Keep reading

DeSantis Frets About Florida ‘Reeking of Marijauna,’ Says He’ll Oppose Legalization

There may not be a more apt visual metaphor for Florida Gov. Ron DeSantis’ past few years than his opposition to a proposed marijuana legalization ballot initiative—which he announced Tuesday while literally standing behind a sign celebrating “Freedom Month.”

“I don’t want this state to be reeking of marijuana,” DeSantis said, defaulting to one of the laziest arguments against pot freedom, but one that DeSantis has been using for years. “We’re doing fine. We don’t need to do that.”

How’s that for Freedom Month?

In fairness to DeSantis, the jarringly dissonant signage was celebrating the state’s sales tax holiday during May. Even so, the gap between DeSantis’ pro-freedom messaging and his actions as governor has become a recurring theme for the one-time presidential hopeful.

After all, this is the same guy who wrote a book titled The Courage To Be Free, but has made a name for himself in conservative politics by wielding state power against drag queens, student groups, and others who have had the courage to freely express their opinions. On the presidential campaign trail, DeSantis would talk up the importance of school choice and parental rights, then moments later promise stricter state control over school curriculums. He’s championed Florida’s status as a refuge for Americans fleeing poor government policies in other states, even as he’s tried to boot out migrants who are voting with their feet by coming to America for the same reason.

Freedom, for DeSantis, seems to mean that you can do whatever you’d please—but only if he approves.

Keep reading